Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease BEFREE SCN4A gene mutations can cause the overlap of PMC and PP (especially the HypoPP2). 30931713 2019
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease BEFREE The voltage gated sodium channel SCN4A mutations account for non-dystrophic myotonia and include a heterogeneous group of conditions that include hyperkalemic periodic paralysis, paramyotonica congenita, potassium-aggravated myotonia, and hypokalemic periodic paralysis type 2. 28012096 2017
Hypokalemic Periodic Paralysis, Type 2
0.730 Biomarker disease GENOMICS_ENGLAND Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy. 26700687 2016
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT NaV1.4 mutations cause hypokalaemic periodic paralysis by disrupting IIIS4 movement during recovery. 24549961 2014
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT Hypokalemic periodic paralysis due to the SCN4A R672H mutation in a Turkish family. 21043388 2010
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT Both hypokalaemic and normokalaemic periodic paralysis in different members of a single family with novel R1129Q mutation in SCN4A gene. 20522878 2010
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. 19118277 2009
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT Cold-induced defects of sodium channel gating in atypical periodic paralysis plus myotonia. 17898326 2008
Hypokalemic Periodic Paralysis, Type 2
0.730 Biomarker disease GENOMICS_ENGLAND A novel dominant mutation of the Nav1.4 alpha-subunit domain I leading to sodium channel myotonia. 19015483 2008
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis. 18162704 2007
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT We identified a novel hypoPP2 mutation that neutralizes an arginine residue in DIII-S4 (R1132Q), and studied its functional consequences in HEK cells transfected with the human SCN4A cDNA. 16890191 2006
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease BEFREE We identified a novel hypoPP2 mutation that neutralizes an arginine residue in DIII-S4 (R1132Q), and studied its functional consequences in HEK cells transfected with the human SCN4A cDNA. 16890191 2006
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis. 11558801 2001
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT Sodium channel gene mutations in hypokalemic periodic paralysis: an uncommon cause in the UK. 11591859 2001
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT Temperature-sensitive sodium channelopathy with heat-induced myotonia and cold-induced paralysis. 10851391 2000
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. 10944223 2000
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease UNIPROT A novel sodium channel mutation in a family with hypokalemic periodic paralysis. 10599760 1999
Hypokalemic Periodic Paralysis, Type 2
0.730 Biomarker disease GENOMICS_ENGLAND
Hypokalemic Periodic Paralysis, Type 2
0.730 Biomarker disease CTD_human
Hypokalemic Periodic Paralysis, Type 2
0.730 GeneticVariation disease CLINVAR
Hypokalemic Periodic Paralysis, Type 2
0.730 CausalMutation disease CLINVAR